CANNASYS INC 0001417028 --12-31 mjtk Yes No No false 2017 Q3 0001417028 2017-01-01 2017-09-30 0001417028 2017-09-30 0001417028 2017-11-09 0001417028 2016-12-31 0001417028 us-gaap:SeriesAPreferredStockMember 2017-09-30 0001417028 us-gaap:SeriesAPreferredStockMember 2016-12-31 0001417028 us-gaap:SeriesBPreferredStockMember 2017-09-30 0001417028 us-gaap:SeriesBPreferredStockMember 2016-12-31 0001417028 2017-07-01 2017-09-30 0001417028 2016-07-01 2016-09-30 0001417028 2016-01-01 2016-09-30 0001417028 2015-12-31 0001417028 2016-09-30 0001417028 2014-11-12 0001417028 2016-10-17 2016-10-17 0001417028 fil:AnEntityOwnedByADirectorMemberus-gaap:PreferredClassAMemberus-gaap:PreferredStockMember 2016-10-17 2016-10-17 0001417028 fil:AnEntityOwnedByADirectorMemberus-gaap:CommonStockMember 2016-10-17 2016-10-17 0001417028 us-gaap:FairValueInputsLevel1Member 2017-09-30 0001417028 us-gaap:FairValueInputsLevel2Member 2017-09-30 0001417028 us-gaap:FairValueInputsLevel3Member 2017-09-30 0001417028 us-gaap:FairValueInputsLevel1Member 2016-12-31 0001417028 us-gaap:FairValueInputsLevel2Member 2016-12-31 0001417028 us-gaap:FairValueInputsLevel3Member 2016-12-31 0001417028 2016-01-01 2016-12-31 0001417028 us-gaap:FurnitureAndFixturesMember 2017-09-30 0001417028 us-gaap:FurnitureAndFixturesMember 2016-12-31 0001417028 us-gaap:FurnitureAndFixturesMember 2017-01-01 2017-09-30 0001417028 us-gaap:FurnitureAndFixturesMember 2017-09-30 2017-09-30 0001417028 us-gaap:FurnitureAndFixturesMember 2016-12-31 2016-12-31 0001417028 us-gaap:FurnitureAndFixturesMember 2016-01-01 2016-12-31 0001417028 us-gaap:FurnitureAndFixturesMember 2016-01-01 2016-06-30 0001417028 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2017-09-30 0001417028 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2016-12-31 0001417028 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2017-01-01 2017-09-30 0001417028 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2016-01-01 2016-09-30 0001417028 fil:DubyLlcMember 2017-09-30 0001417028 fil:AfnMember 2017-09-30 0001417028 fil:BetaKillersLlcMemberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BetaKillersLlcMember 2017-09-30 0001417028 fil:BetaKillersLlcMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember 2017-01-01 2017-09-30 0001417028 fil:OfficeSpaceMember 2017-01-01 2017-09-30 0001417028 fil:OfficeSpaceMember 2017-09-30 0001417028 us-gaap:ChiefExecutiveOfficerMember 2017-01-01 2017-09-30 0001417028 us-gaap:ChiefExecutiveOfficerMemberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:FormerOfficerMember 2017-01-01 2017-09-30 0001417028 fil:FormerOfficerMember 2017-09-30 0001417028 fil:EachDirectorMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember 2017-01-01 2017-09-30 0001417028 fil:AnInvestorMember 2016-04-27 0001417028 fil:AnInvestorMember 2016-01-01 2016-12-31 0001417028 fil:BlackbridgeCapitalLlcMemberus-gaap:ConvertibleNotesPayableMember 2016-05-05 0001417028 fil:BlackbridgeCapitalLlcMemberus-gaap:ConvertibleNotesPayableMember 2017-01-01 2017-09-30 0001417028 fil:BlackbridgeCapitalLlcMemberus-gaap:ConvertibleNotesPayableMember 2017-09-30 0001417028 fil:BlackbridgeCapitalLlcMemberfil:PrincipalMemberus-gaap:ConvertibleNotesPayableMember 2016-01-01 2016-12-31 0001417028 fil:BlackbridgeCapitalLlcMemberfil:PrincipalMemberus-gaap:ConvertibleNotesPayableMember 2017-09-30 0001417028 fil:BlackbridgeCapitalLlcMemberfil:InterestMemberus-gaap:ConvertibleNotesPayableMember 2017-09-30 0001417028 fil:EmaFinancialLlcMemberfil:N10142015NoteMember 2016-01-01 2016-12-31 0001417028 fil:EmaFinancialLlcMemberfil:N10142015NoteMember 2016-12-31 0001417028 fil:TangiersInvestmentGroupLlcMemberfil:N11182015NoteMember 2016-01-01 2016-12-31 0001417028 fil:TangiersInvestmentGroupLlcMemberfil:N11182015NoteMember 2016-12-31 0001417028 fil:KodiakCapitalMemberfil:N11302015NoteMember 2016-01-01 2016-12-31 0001417028 fil:KodiakCapitalMemberfil:N11302015NoteMember 2016-12-31 0001417028 fil:AuctusFundLlcMemberfil:N12032015NoteMember 2016-01-01 2016-12-31 0001417028 fil:AuctusFundLlcMemberfil:N12032015NoteMember 2016-12-31 0001417028 fil:KodiakCapitalMemberfil:N12152015NoteMember 2016-01-01 2016-12-31 0001417028 fil:KodiakCapitalMemberfil:N12152015NoteMember 2016-12-31 0001417028 fil:AdarBaysLlcMemberfil:N12162015NoteMember 2016-01-01 2016-12-31 0001417028 fil:AdarBaysLlcMemberfil:N12162015NoteMember 2016-12-31 0001417028 fil:ColonialStockTransferMemberfil:N01142016NoteMember 2016-01-01 2016-12-31 0001417028 fil:ColonialStockTransferMemberfil:N01142016NoteMember 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N04272016NoteMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N04272016NoteMember 2016-01-01 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N04272016NoteMember 2016-12-31 0001417028 fil:EmaFinancialLlcMemberfil:N05052016NoteMember 2016-01-01 2016-12-31 0001417028 fil:EmaFinancialLlcMemberfil:N05052016NoteMember 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N053120161NoteMember 2016-01-01 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N053120161NoteMember 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N053120162NoteMember 2016-01-01 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N053120162NoteMember 2016-12-31 0001417028 fil:AdarBaysLlcMemberfil:N07122016NoteMember 2016-01-01 2016-12-31 0001417028 fil:AdarBaysLlcMemberfil:N07122016NoteMember 2016-12-31 0001417028 fil:AuctusFundLlcMemberfil:N07202015NoteMember 2016-01-01 2016-12-31 0001417028 fil:AuctusFundLlcMemberfil:N07202015NoteMember 2016-12-31 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N10132016NoteMember 2016-01-01 2016-12-31 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N10132016NoteMember 2016-12-31 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N10212016NoteMember 2016-01-01 2016-12-31 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N10212016NoteMember 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N10242016NoteMember 2016-01-01 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N10242016NoteMember 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N11042016NoteMember 2016-01-01 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N11042016NoteMember 2016-12-31 0001417028 fil:AuctusFundLlcMemberfil:N12072016NoteMember 2016-01-01 2016-12-31 0001417028 fil:AuctusFundLlcMemberfil:N12072016NoteMember 2016-12-31 0001417028 fil:AdarBaysLlcMemberfil:N12122016NoteMember 2016-01-01 2016-12-31 0001417028 fil:AdarBaysLlcMemberfil:N12122016NoteMember 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N12142016NoteMember 2016-01-01 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N12142016NoteMember 2016-12-31 0001417028 fil:AdarBaysLlcMemberfil:N12202016NoteMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N12202016NoteMember 2016-01-01 2016-12-31 0001417028 fil:AdarBaysLlcMemberfil:N12202016NoteMember 2016-12-31 0001417028 fil:BlackForestCapitalLlcMemberfil:N04272016NoteMember 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N12202016NoteMember 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01232017NoteMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01232017NoteMember 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N02152017NoteMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N02152017NoteMember 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N03102017NoteMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N03102017NoteMember 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N04282017NoteMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N04282017NoteMember 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N05152017NoteMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N05152017NoteMember 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N07192017Member 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N07192017Member 2017-09-30 0001417028 fil:BnaInvestmentCapitalLlcMemberfil:N08182017Member 2017-01-01 2017-09-30 0001417028 fil:BnaInvestmentCapitalLlcMemberfil:N08182017Member 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N09112017Member 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N09112017Member 2017-09-30 0001417028 fil:BnaInvestmentCapitalLlcMemberfil:N09182017Member 2017-01-01 2017-09-30 0001417028 fil:BnaInvestmentCapitalLlcMemberfil:N09182017Member 2017-09-30 0001417028 2017-03-31 0001417028 us-gaap:ChiefExecutiveOfficerMember 2015-12-24 0001417028 us-gaap:ChiefExecutiveOfficerMemberus-gaap:WarrantMember 2015-10-01 2015-12-31 0001417028 us-gaap:ChiefExecutiveOfficerMemberus-gaap:WarrantMember 2017-01-01 2017-09-30 0001417028 us-gaap:ChiefExecutiveOfficerMemberus-gaap:WarrantMember 2017-09-30 0001417028 fil:Director1Member 2015-12-24 0001417028 fil:Director1Memberus-gaap:WarrantMember 2017-01-01 2017-09-30 0001417028 fil:Director1Memberus-gaap:WarrantMember 2017-09-30 0001417028 fil:Director2Member 2015-12-24 0001417028 fil:Director2Memberus-gaap:WarrantMember 2017-01-01 2017-09-30 0001417028 fil:Director2Memberus-gaap:WarrantMember 2017-09-30 0001417028 fil:Director3Member 2015-12-24 0001417028 fil:Director3Memberus-gaap:WarrantMember 2015-10-01 2015-12-31 0001417028 fil:Director3Memberus-gaap:WarrantMember 2017-01-01 2017-09-30 0001417028 fil:Director3Memberus-gaap:WarrantMember 2017-09-30 0001417028 fil:Investor2Member 2016-01-21 0001417028 fil:Investor2Memberus-gaap:WarrantMember 2017-01-01 2017-09-30 0001417028 fil:Investor2Memberus-gaap:WarrantMember 2017-09-30 0001417028 fil:Investor3Member 2016-01-24 0001417028 fil:Investor3Memberus-gaap:WarrantMember 2017-09-30 0001417028 fil:Investor3Memberus-gaap:WarrantMember 2017-01-01 2017-09-30 0001417028 fil:Investor4Member 2016-04-28 0001417028 fil:Investor4Memberus-gaap:WarrantMember 2017-01-01 2017-09-30 0001417028 fil:Investor4Memberus-gaap:WarrantMember 2017-09-30 0001417028 us-gaap:WarrantMember 2016-12-31 0001417028 us-gaap:WarrantMember 2016-01-01 2016-12-31 0001417028 us-gaap:WarrantMember 2017-01-01 2017-09-30 0001417028 us-gaap:WarrantMember 2017-09-30 0001417028 us-gaap:SeriesAPreferredStockMember 2017-01-01 2017-09-30 0001417028 us-gaap:SeriesBPreferredStockMember 2017-01-01 2017-09-30 0001417028 us-gaap:DirectorMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember 2017-01-01 2017-09-30 0001417028 us-gaap:DirectorMemberus-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember 2017-09-30 0001417028 fil:BetaKillersLlcMemberus-gaap:SeriesBPreferredStockMemberus-gaap:PreferredStockMember 2017-09-30 0001417028 2017-09-20 0001417028 fil:KodiakCapitalMemberus-gaap:CommonStockMember 2017-02-02 0001417028 fil:KodiakCapitalMember 2017-02-02 2017-02-02 0001417028 fil:KodiakCapitalMemberus-gaap:CommonStockMember 2017-09-30 0001417028 fil:KodiakCapitalMember 2017-01-01 2017-09-30 0001417028 us-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:EmaFinancialLlcMemberfil:N01032017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:EmaFinancialLlcMemberfil:N01032017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:EmaFinancialLlcMemberfil:N01042017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:EmaFinancialLlcMemberfil:N01042017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N01052017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N01052017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01052017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01052017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:EmaFinancialLlcMemberfil:N01062017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:EmaFinancialLlcMemberfil:N01062017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01112017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01112017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01132017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01132017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:EmaFinancialLlcMemberfil:N01132017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:EmaFinancialLlcMemberfil:N01132017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N01132017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N01132017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01172017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01172017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N01172017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N01172017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:TangiersInvestmentGroupLlcMemberfil:N01172017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:TangiersInvestmentGroupLlcMemberfil:N01172017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01182017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01182017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:KodiakCapitalMemberfil:N01182017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:KodiakCapitalMemberfil:N01182017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01192017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N01192017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:KodiakCapitalMemberfil:N01192017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:KodiakCapitalMemberfil:N01192017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AuctusFundLlcMemberfil:N01202017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AuctusFundLlcMemberfil:N01202017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:ColonialStockTransferMemberfil:N01202017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:ColonialStockTransferMemberfil:N01202017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:KodiakCapitalMemberfil:N01242017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:KodiakCapitalMemberfil:N01242017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AuctusFundLlcMemberfil:N01302017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AuctusFundLlcMemberfil:N01302017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:KodiakCapitalMemberfil:N02132017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:KodiakCapitalMemberfil:N02132017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:KodiakCapitalMemberfil:N02142017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:KodiakCapitalMemberfil:N02142017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AuctusFundLlcMemberfil:N02152017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AuctusFundLlcMemberfil:N02152017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N04252017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N04252017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N05042017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N05042017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N05102017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N05102017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N06142017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N06142017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N06202017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N06202017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N06122017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:MicrocapEquityGroupLlcMemberfil:N06122017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N06192017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N06192017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N06212017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N06212017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N07112017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N07112017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N07172017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N07172017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N07242017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N07242017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N08032017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N08032017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N08182017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N08182017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N08212017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N08212017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N08282017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N08282017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N08282017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N08282017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N09112017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N09112017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N09112017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N09112017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N09142017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:AdarBaysLlcMemberfil:N09142017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N09192017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N09192017Memberfil:PrincipalMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N09292017Memberus-gaap:CommonStockMember 2017-01-01 2017-09-30 0001417028 fil:BlackForestCapitalLlcMemberfil:N09292017Memberfil:PrincipalMember 2017-01-01 2017-09-30 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

 

SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2017

 

 

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

 

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________

 

Commission File No. 000-54476

 

CANNASYS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada

880367706

(State or other jurisdiction of

(IRS Employer

incorporation or organization)

Identification No.)

 

1350 17th Street, Suite 150, Denver, CO  80202

(Address of principal executive offices and zip code)

 

(720) 420-1290

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes

[X]

No

[  ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes

[X]

No

[  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [  ]

Accelerated filer [  ]

Non-accelerated filer [  ]

Smaller Reporting Company [X]

Emerging growth company [  ]

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

Yes

[  ]

No

[X]

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of November 9, 2017, there were 1,880,974,110 shares of common stock, $0.001 par value, outstanding.


CANNASYS, INC.

Form 10-Q for the Three Months Ended September 30, 2017

 

 

 

TABLE OF CONTENTS

 

 

Item

 

Page

 

Part I—Financial Information

 

 

 

 

1

Financial Statements (Unaudited)

 

 

Balance Sheets

3

 

Statements of Operations

4

 

Statements of Cash Flows

5

 

Notes to the Financial Statements

6

2

Management’s Discussion and Analysis of Financial Condition and Results of Operations

16

3

Quantitative and Qualitative Disclosures about Market Risk

21

4

Controls and Procedures

21

 

 

 

 

Part II—Other Information

 

 

 

 

2

Unregistered Sales of Equity Securities and Use of Proceeds

22

5

Other Information

22

6

Exhibits

23

 

Signature Page

24


2


PART I–FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

 

CANNASYS, INC.

 

Condensed Balance Sheets

 

 

September 30,

 

December 31,

 

2017

 

2016

 

 

(unaudited)

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

Cash

$

2,023 

 

$

7,090 

Total Current Assets

 

2,023 

 

 

7,090 

Software, net of amortization of $122,912 and $40,264, respectively

 

98,088 

 

 

180,736 

Available-for-sale securities

 

57,500 

 

 

32,500 

Deposit

 

1,500 

 

 

1,500 

Total Assets

$

159,111 

 

$

221,826 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

Accounts payable

$

126,713 

 

$

462,320 

Accrued expenses

 

9,342 

 

 

130,091 

Notes payable

 

243,440 

 

 

27,000 

Notes payable – related party

 

114,226 

 

 

Convertible notes payable, net of discount of $35,033 and $87,908, respectively

 

248,639 

 

 

353,740 

Total Current Liabilities

 

742,360 

 

 

973,151 

 

 

 

 

 

 

Total Liabilities

 

742,360 

 

 

973,151 

 

 

 

 

 

 

Stockholders’ Equity (Deficit):

 

 

 

 

 

Preferred stock, $0.001 par value, 5,000,000 shares authorized

 

 

 

 

 

Series A Preferred stock, $0.001 par value,

2,500,000 and 0 issued and outstanding, respectively

 

2,500 

 

 

Series B Preferred stock, $0.001 par value,

2,000,000 and 0 issued and outstanding, respectively

 

2,000 

 

 

Common stock, $0.001 par value, 2,000,000,000 shares authorized,

  1,759,060,598 and 355,734,404 shares issued and

  outstanding, respectively

 

1,759,153 

 

 

355,734 

Additional paid-in capital

 

13,258,288 

 

 

9,357,233 

Accumulated deficit

 

(15,605,190)

 

 

(10,464,292)

Total Stockholders’ Deficit

 

(583,249)

 

 

(751,325)

 

 

 

 

 

 

Total Liabilities and Stockholders’ Deficit

$

159,111 

 

$

221,826 

 

 

 

The accompanying notes are an integral part of these condensed unaudited financial statements.


3


CANNASYS, INC.

 

Condensed Statements of Operations

(Unaudited)

 

 

For the Three Months

 

For the Nine Months

 

Ended September 30,

 

Ended September 30,

 

2017

 

2016

 

2017

 

2016

Sales revenue

$

 

$

499 

 

$

 

$

59,150 

Cost of goods sold

 

 

 

 

 

 

 

24,260 

Gross margin

 

 

 

499 

 

 

 

 

34,890 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

Stock-based compensation expense

 

13,406 

 

 

119,125 

 

 

101,531 

 

 

604,592 

Professional fees

 

121,246 

 

 

95,286 

 

 

251,156 

 

 

307,713 

Salary and wage expense

 

57,175 

 

 

49,092 

 

 

141,175 

 

 

183,793 

General and administrative

 

109,915 

 

 

68,240 

 

 

238,052 

 

 

198,261 

Total operating expenses

 

301,742 

 

 

331,743 

 

 

731,914 

 

 

1,294,359 

 

 

 

 

 

 

 

 

 

 

 

 

Loss from operations

 

(301,742)

 

 

(331,244)

 

 

(731,914)

 

 

(1,259,469)

 

 

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

(4,822)

 

 

(12,749)

 

 

(15,017)

 

 

(29,204)

Interest expense–debt discount and loan financing fees

 

(189,068)

 

 

(86,291)

 

 

(650,022)

 

 

(502,140)

Impairment loss on investment

 

 

 

(599,475)

 

 

 

 

(599,475)

Loss on fixed and intangible assets

 

 

 

(258,766)

 

 

 

 

(258,766)

Debt penalties and settlement costs

 

(85,741)

 

 

 

 

(85,741)

 

 

Loss on issuance of convertible debt

 

(349,106)

 

 

(418,079)

 

 

(2,504,411)

 

 

(907,090)

Gain on forgiveness/settlement of debt

 

 

 

40,000 

 

 

2,000 

 

 

40,000 

Increased valuation of preferred stock

 

(1,155,793)

 

 

-

 

 

(1,155,793)

 

 

-

Total other expense

 

(1,784,530)

 

 

(1,335,360)

 

 

(4,408,984)

 

 

(2,256,675)

 

 

 

 

 

 

 

 

 

 

 

 

Loss before provision for income taxes

 

(2,086,272)

 

 

(1,666,604)

 

 

(5,140,898)

 

 

(3,516,144)

Provision for income taxes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

$

(2,086,272)

 

$

(1,666,604)

 

$

(5,140,898)

 

$

(3,516,144)

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted loss per common share

$

(0.00)

 

$

(0.50)

 

$

(0.01)

 

$

(1.77)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of

  common shares outstanding

 

1,450,936,026 

 

 

3,365,342 

 

 

948,513,559 

 

 

1,990,980 

 

 

 

The accompanying notes are an integral part of these condensed unaudited financial statements.


4


CANNASYS, INC.

 

Condensed Statements of Cash Flows

(Unaudited)

 

 

For the Nine Months Ended

 

September 30,

 

2017

 

2016

Cash flow from operating activities

 

 

 

 

 

Net loss

$

(5,140,898)

 

$

(3,516,144)

Adjustments to reconcile net loss to net cash

 used in operating activities:

 

 

 

 

 

Depreciation

 

82,648 

 

 

13,824 

Stock-based compensation

 

101,531 

 

 

604,592 

Amortization of debt discount

 

650,022 

 

 

502,140 

Severance expense

 

28,000 

 

 

33,717 

Impairment loss on investment

 

 

 

599,475 

Debt penalties and settlement costs

 

85,741 

 

 

Loss on issuance of convertible debt

 

2,504,411 

 

 

907,090 

Loss on fixed and intangible assets

 

 

 

258,766 

Gain on forgiveness of debt

 

(2,000)

 

 

(40,000)

Increased valuation of preferred stock

 

1,155,793

 

 

-

Change in operating assets and liabilities:

 

 

 

 

 

Accounts receivable

 

 

 

4,550 

Other assets

 

 

 

(1,500)

Related-party payable

 

(57,995)

 

 

Accounts payable

 

8,477 

 

 

237,799 

Accrued expenses

 

(25,354)

 

 

87,831 

Net cash used in operating activities

 

(609,624)

 

 

(307,860)

 

 

 

 

 

 

Cash flows used in investing activities:

 

 

 

 

 

Purchase of available-for-sale securities

 

(25,000)

 

 

Net cash used in investing activities

 

(25,000)

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Proceeds from loans

 

499,627 

 

 

315,500 

Payments on loans

 

(40,750)

 

 

(13,500)

Proceeds from the sale of common stock

 

170,680 

 

 

Net cash provided by financing activities

 

629,557 

 

 

302,000 

 

 

 

 

 

 

Net decrease in cash

 

(5,067)

 

 

(5,860)

Cash at beginning of the period

 

7,090 

 

 

7,720 

Cash at end of the period

$

2,023 

 

$

1,860 

 

 

 

 

 

 

Supplemental Disclosures:

 

 

 

 

 

Interest paid

$

 

$

Income taxes paid

$

 

$

 

 

 

 

 

 

Supplemental disclosure of noncash activities

 

 

 

 

 

Preferred stock issued for services

$

2,838,000 

 

$

Common stock issued for services

$

2,031 

 

$

117,500 

Issuance of convertible notes payable

$

3,026,039

 

$

1,269,193 

Common stock issued for software

$

 

$

221,000 

 

 

 

The accompanying notes are an integral part of these condensed unaudited financial statements.


5


CANNASYS, INC.

Notes to the Financial Statements

September 30, 2017

(Unaudited)

 

 

 

NOTE 1—ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Organization

We were organized as a Nevada corporation on August 25, 1999. On August 15, 2014, we entered into an Agreement and Plan of Merger to combine our business and activities with CannaSys, Inc., a privately held Colorado corporation focused on providing services to the cannabis industry (“CannaSys-Colorado”), into a single entity (the “Merger”). CannaSys-Colorado was originally formed on October 4, 2013, as a limited liability company, and converted to a corporation on June 26, 2014. Under the terms of the merger agreement, our wholly owned subsidiary formed to effectuate the Merger was merged with and into CannaSys-Colorado, the surviving entity, which then became our wholly owned subsidiary.

 

Due to the CannaSys-Colorado shareholders controlling us after the Merger, CannaSys-Colorado was considered the accounting acquirer. The transaction was therefore recognized as a reverse acquisition of us by CannaSys-Colorado.

 

In connection with the closing of the Merger and after meeting the requirements of the Securities Exchange Act of 1934, as amended (“Exchange Act”), on November 12, 2014, we filed amended and restated articles of incorporation with the Nevada Secretary of State that: (i) changed our name to CannaSys, Inc.; (ii) increased our authorized capital stock to 80,000,000 shares, consisting of 75,000,000 shares of common stock and 5,000,000 shares of preferred stock; (iii) authorized 5,000,000 shares of preferred stock; and (iv) made other modernizing, nonmaterial changes to our articles of incorporation. Changing our corporate name to CannaSys, Inc. was a condition to the Merger transaction. The name change better reflected the nature of our principal business operations and it became effective in the OTC market on December 2, 2014, when FINRA announced the name change. We also received a new CUSIP number and our trading symbol was changed to “MJTK.”

 

On October 17, 2016, we completed a recapitalization of our company, consisting of a 20-to-one reverse split and an increase of authorized capitalization. Our amended and restated articles of incorporation authorize us to issue 2,005,000,000 shares of capital stock, consisting of 2,000,000,000 shares of common stock, par value $0.001, and 5,000,000 shares of preferred stock, par value $0.001. This recapitalization triggered the automatic conversion of 1,515,000 shares of Series A Preferred Stock to 75,750 shares of common stock.

 

Nature of Business

We provide technology services in the ancillary space of the cannabis industry. We do not produce, sell, or handle in any manner cannabis products. As the current cannabis industry grows and gains momentum around the country, technology needs for the industry have been largely underserved. Our focus on this niche element of the industry creates many efficient and profitable tools for both industry owners and consumers.

 

Since inception, we have developed, refined, and introduced branded products, membership loyalty programs, text-message-based platforms for customer engagement, and laboratory management systems into the cannabis industry. To support marketing and delivery of our principal products and to access other products and services, we are expanding a network of strategic alliances within the industry to build an array of product and service offerings and to increase use of our distribution channels. Most of our active strategic relationships were only recently initiated and are yet to generate revenue.

 

We seek funding to launch our integrated cannabis-industry product and service suite. Our primary business objectives are to generate stable revenues and cash flows through the development of vertically integrated distribution centers and to collect and monetize cannabis consumer data.


6


NOTE 2—SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Unaudited Interim Financial Information

The accompanying unaudited interim condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These financial statements should be read in conjunction with the audited financial statements and footnotes included in our Annual Report on Form 10-K for the year ended December 31, 2016. The results of the nine months ended September 30, 2017, are not necessarily indicative of the results to be expected for the full year ending December 31, 2017.

 

Use of Estimates

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Fair Value of Financial Instruments

We follow Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 825-10-50-10, Financial Instruments—Overall—Disclosure, for disclosures about fair value of our financial instruments and ASC 820-10-35-37, Fair Value Measurement—Overall—Subsequent Measure—Fair Value Hierarchy, to measure the fair value of our financial instruments. ASC 820-10-35-37 establishes a U.S. GAAP framework for measuring fair value and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820-10-35-37 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by ASC 820-10-35-37 are described below:

 

Level 1:

 

Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.

 

 

 

Level 2:

 

Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.

 

 

 

Level 3:

 

Pricing inputs that are generally observable inputs and not corroborated by market data.

 

The carrying amount of our financial assets and liabilities, such as cash, prepaid expenses, and accrued expenses, approximate their fair value because of the short maturity of those instruments. Our notes payable approximate the fair value of such instruments based upon management’s best estimate of interest rates that would be available to us for similar financial arrangements at September 30, 2017.

 

The following table presents assets and liabilities that are measured and recognized at fair value on a recurring basis:

 

 

 

 

 

 

 

 

Total Gains

Description

Level 1

 

Level 2

 

Level 3

 

and (Losses)

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2017:

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

$

-

 

$

-

 

$

57,500

 

$

-

Total

$

-

 

$

-

 

$

57,500

 

$

-

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2016:

 

 

 

 

 

 

 

 

 

 

 

Available-for-sale securities

$

-

 

$

-

 

$

32,500

 

$

-

Total

$

-

 

$

-

 

$

32,500

 

$

-


7


Recently Issued Accounting Pronouncements

In February 2016, the FASB issued Accounting Standards Update (“ASU”) 2016-02— Leases (Topic 842) . The guidance in ASU 2016-02 supersedes the lease recognition requirements in ASC 840, Leases (FAS 13) . ASU 2016-02 requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases, along with additional qualitative and quantitative disclosures. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, with early adoption permitted. We are currently evaluating the effect this standard will have on our financial statements.

 

In June 2016, the FASB issued ASU 2016-15— Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (a consensus of the FASB’s Emerging Issues Task Force) . The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The ASU is effective for public companies for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including interim periods within those fiscal years. An entity that elects early adoption must adopt all of the amendments in the same period. The guidance requires application using a retrospective transition method. We are currently evaluating the effects, if any, that the adoption of this guidance will have on our cash flows.

 

We have implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and we do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

 

 

NOTE 3—GOING CONCERN

 

As reflected in the accompanying financial statements, we have an accumulated deficit of $15,605,190 at September 30, 2017, had a net loss of $5,140,898, and used net cash of $609,624 in operating activities for the nine months September 30, 2017. These factors raise substantial doubt about our ability to continue as a going concern. The financial statements have been prepared assuming that we will continue as a going concern. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should we be unable to continue as a going concern.

 

While we are attempting to increase operations and revenues, our cash position may not be significant enough to support our daily operations. Management intends to raise additional funds by way of debt and equity financing. Management believes that the actions presently being taken to further implement our business plan and generate increased revenues provide the opportunity for us to continue as a going concern. While we believe in the viability of our strategy to generate increased revenues and in our ability to raise additional funds, there can be no assurances to that effect. Our ability to continue as a going concern is dependent upon our ability to further implement our business plan and generate increased revenues. The financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern.

 

NOTE 4—PROPERTY AND EQUIPMENT

 

Furniture, fixtures, and equipment, stated at cost, less accumulated depreciation consisted of the following at:

 

 

September 30,

 

December 31,

 

2017

 

2016

 

 

 

 

 

 

Furniture, fixtures, and equipment

$

        -

 

$

 8,403 

Less: accumulated depreciation

 

-

 

 

(4,637)

Loss on disposal

 

-

 

 

(3,766)

Fixed assets, net

$

       -

 

$

         - 

 

During the year ended December 31, 2016, we disposed of $8,403 of office furniture we were no longer using, resulting in a loss on disposal of $3,766.


8


 

Depreciation Expense

Depreciation expense for the nine months ended September 30, 2017 and 2016, was $0 and $13,824, respectively.

 

Software, stated at cost, less accumulated amortization consisted of the following at:

 

 

September 30,

 

December 31,

 

2017

 

2016

 

 

 

 

Software

$   221,000 

 

$        -

Less: accumulated amortization

(122,912)

 

-

Fixed assets, net

$   98,088 

 

$        -

 

Amortization Expense

Amortization expense for the software for nine months ended September 30, 2017 and 2016, was $122,912 and $0, respectively.

 

NOTE 5 AVAILABLE-FOR-SALE SECURITIES

 

On December 10, 2015, we acquired a 1.083% interest in Duby, LLC for $32,500. Duby is a social media application focused on cannabis consumers. As part of the acquisition, Duby plans to assist in the promotion of our products and services on its platform. We purchased the interest in Duby as part of ongoing negotiations for the joint marketing and promotion of our respective products. The purchase is being accounted for according to ASC 320, Debt and Equity Securities , as available-for-sale securities and has been recorded at cost. As Duby is not a public company with active trading by which the investment could be valued at September 30, 2017, we performed an impairment analysis and determined that as of September 30, 2017, there had been no impairment to the value of the purchased interest in Duby based on subsequent financings undertaken by Duby with third parties that substantiated the reported valuation.

 

On February 12, 2017, we acquired 2,500,000 shares of stock in Alliance Financial Network, Inc. (“AFN”) for $25,000. The shares were purchased pursuant to a non-binding letter of intent in which we were to acquire 100% of the assets of AFN. That letter of intent was terminated on May 9, 2017. As AFN is not a public company with active trading by which the investment could be valued at September 30, 2017, we performed an impairment analysis and determined that as of September 30, 2017, there had been no impairment to the value of the purchased interest in AFN.

 

NOTE 6—ASSET PURCHASE

 

On August 10, 2016, we entered into an Asset Purchase Agreement and a General Assignment and Bill of Sale, with Beta Killers LLC, a Colorado limited liability company, whereby we acquired all of the assets comprising the current version of the Citizen Toke application, including all Intellectual Property (as defined in the agreement), code, and other intangibles and related documentation associated with Citizen Toke. The purchase price was 1,000,000 shares of common stock. The shares were valued at $0.22 per share, the closing price on the date of purchase, for a total purchase price of $221,000. The software is being amortized over its estimated useful life of three years.

 

On September 20, 2017, we issued 2,000,000 shares of Series B Preferred Stock to Beta Killers LLC, as consideration for and in exchange of its agreement to waive our prior defaults, release us from our obligations under the asset purchase agreement and related agreements, and enter into an additional statement of work under our master services agreement.

 

NOTE 7—COMMITMENTS AND CONTINGENCIES

 

Operating Lease

We currently sublease office space in Denver, Colorado. We signed a month-to-month lease starting January 1, 2016. Current lease payments are based on number of desks being occupied not to exceed $1,500 per month. The sublease required a deposit of $1,500, which was paid on January 25, 2016.


9


NOTE 8—RELATED-PARTY TRANSACTIONS

 

Refer to Note 12 for warrants issued.

 

On July 1, 2017, we entered into an executive employment agreement with Patrick G. Burke to serve as our chief executive officer, chief financial officer, and corporate secretary for a term of one year, with automatic renewals, unless terminated. Mr. Burke’s compensation in this position consists of an annual base salary of $84,000. In connection therewith, Mr. Burke was awarded 2,250,000 shares of our common stock, to vest in equal quarterly increments over a one-year period. Mr. Burke was also appointed to our board of directors, to serve until his successor is elected and qualified.

 

Effective July 1, 2017, Michael Tew resigned as our chief executive officer, chief financial officer, and corporate secretary, his employment agreement was terminated, and he entered into a consulting agreement and a separation and mutual release agreement with us. Mr. Tew continues to serve as a director. In connection therewith, we issued to Mr. Tew a promissory note in the amount of $44,380 for his past-due compensation and severance, which was paid in full on September 11, 2017. In addition. Mr. Tew received a bonus, for services provided, of $22,175.

 

On September 11, 2017, our board appointed Ben Tyson, founder of Beta Killers LLC, as one of our directors, to serve until his successor is elected and qualified.

 

On September 20, 2017, we issued 2,000,000 shares of Series B Preferred Stock to Beta Killers LLC, as consideration for and in exchange of its agreement to waive our prior defaults, release us from our obligations under the asset purchase agreement and related agreements, and enter into an additional statement of work under our master services agreement. Our director Ben Tyson is also managing member and chief executive officer of Beta Killers LLC.

 

On September 20, 2017, we issued 500,000 shares of Series A Preferred Stock to each of our directors in consideration of their future service on our board.

 

NOTE 9—NOTE PAYABLE

 

On April 27, 2016, we issued a promissory note for $27,000 to an investor in conjunction with assignment of his note dated June 26, 2015, to another investor. The note included a $25,000 cash payment and a $2,000 original issue discount. The note is unsecured, accrues interest at 1% per annum, and is due and payable on October 26, 2016. In connection with the execution of the promissory note, we also issued a warrant to purchase 5,000 shares of common stock (Note 12). On January 5, 2017, this note was assigned to and purchased by Microcap Equity Group LLC, which converted the debt in full in January.

 

NOTE 10 NOTE PAYABLE IN DEFAULT

 

On May 5, 2016, we issued to Blackbridge Capital, LLC, a Convertible Promissory Note in the principal amount of $50,000 (the “Amended Note”). The Amended Note amends and restates an unsecured promissory note of $50,000, dated June 26, 2015, in favor of Jeff Holmes (the “Original Note”), which Mr. Holmes assigned to Blackbridge as part of the transaction under an Assignment and Assumption Agreement. As consideration for Mr. Holmes’ assignment of the Original Note to Blackbridge, Blackbridge paid $48,000 to Mr. Holmes, retaining $2,000 for its legal fees. The Amended Note accrues interest at the rate of 1% per annum, is convertible into shares of common stock at a conversion price of 50% of the lowest trading price in the 20 trading days before the conversion date, and matured on October 27, 2016. During the year ended December 31, 2016, $45,500 of principal was converted to shares of common stock. As of September 30, 2017, there is $4,500 and $87 of principal and accrued interest due on this note, respectively. This note is currently in default.


10


NOTE 11—CONVERTIBLE NOTES PAYABLE

 

The following is a summary of outstanding convertible promissory notes as of December 31, 2016:

 

 

 

 

Stated

Principal Balance

Note Holder

Issue Date

Maturity Date

Interest Rate

Outstanding

 

 

 

 

 

 

EMA Financial, LLC

10/14/2015

10/14/2016

12%

$           - 

(1)

Tangiers Investment Group, LLC

11/18/2015

11/19/2016

10%

2,216 

(2)

Kodiak Capital Group, LLC

11/30/2015

12/01/2016

12%

44,687 

(3)

Auctus Fund, LLC

12/03/2015

09/03/2016

10%

(4)

Kodiak Capital Group, LLC

12/15/2015

07/15/2016

0%

50,000 

 

Adar Bays, LLC

12/16/2015

12/16/2016

8%

(5)

Colonial Stock Transfer

01/14/2016

01/14/2017

10%

7,507 

(6)

Blackbridge Capital, LLC

04/27/2016

10/27/2016

1%

4,500 

(7)

EMA Financial, LLC

05/05/2016

05/05/2017

12%

32,883 

(8)

Black Forest Capital, LLC

05/31/2016

05/31/2017

8%

(9)

Black Forest Capital, LLC

05/31/2016

05/31/2017

2%

(10)

Adar Bays, LLC

07/12/2016

04/12/2017

8%

(11)

Auctus Fund, LLC

07/20/2016

04/20/2017

10%

45,750 

 

Microcap Equity Group LLC

10/13/2016

10/13/2017

12%

(12)

Microcap Equity Group LLC

10/21/2016

10/21/2017

12%

7,400 

 

Black Forest Capital, LLC

10/24/2016

04/24/2017

8%

78,600 

(13)

Black Forest Capital, LLC

11/04/2016

11/04/2017

8%

27,500 

 

Auctus Fund, LLC

12/07/2016

09/07/2017

12%

40,750 

 

Adar Bays, LLC

12/12/2016

12/12/2017

8%

14,855 

(14)

Black Forest Capital, LLC

12/14/2016

12/14/2017

8%

27,500 

 

Adar Bays, LLC

12/20/2016

12/12/2017

8%

57,500 

 

 

 

 

 

$441,648 

 

Less debt discount:

 

 

 

(87,908)

 

Convertible notes payable, net of discount:

 

 

 

$353,740 

 

_______________

(1)    Converted $33,300 of principal to common stock.

(2)    Converted $57,784 of principal to common stock.

(3)    Converted $5,313 of principal to common stock.

(4)    Converted $49,250 of principal to common stock.

(5)    Converted $35,000 of principal to common stock.

(6)    Converted $2,400 of principal to common stock.

(7)    Converted $45,500 of principal to common stock.

(8)    Converted $20,617 of principal to common stock.

(9)    Converted $30,000 of principal to common stock.

(10)  Converted $50,000 of principal to common stock.

(11)  Converted $35,000 of principal to common stock

(12)  Converted $50,000 of principal to common stock

(13)  Converted $48,900 of principal to common stock

(14)  Converted $60,156 of principal to common stock

 

Accrued interest on the above notes was $23,700 as of December 31, 2016.


11


 

The following is a summary of outstanding convertible promissory notes as of September 30, 2017:

 

 

 

 

Stated

Principal Balance

Note Holder

Issue Date

Maturity Date

Interest Rate

Outstanding

 

 

 

 

 

 

Blackbridge Capital, LLC

04/27/2016

10/27/2016

1%

$     4,500 

(1)

Adar Bays LLC

12/20/2016

12/12/2017

8%

(2)

Black Forest Capital, LLC

01/23/2017

01/23/2018

8%

(3)

Black Forest Capital, LLC

02/15/2017

02/15/2018

8%

(4)

Black Forest Capital, LLC

03/10/2017

03/10/2018

8%

47,757 

(5)

Black Forest Capital, LLC

04/28/2017

04/28/2018

8%

28,875 

 

Adar Bays LLC

05/15/2017

12/12/2017

8%

(6)

Adar Bays LLC

07/19/2017

02/15/2017

8%

-

(7)

BNA Investment Capital, LLC

08/18/2017

08/18/2018

8%

55,000

 

Black Forest Capital, LLC

09/11/2017

09/11/2018

8%

92,540

 

BNA Investment Capital, LLC

09/18/2017

9/18/2017

8%

55,000

 

 

 

 

 

283,672

 

Less debt discount:

 

 

 

(35,033)

 

Convertible notes payable, net of discount:

 

 

 

248,639

 

_______________

(1)  Converted $45,500 of principal to common stock.

(2)  Converted $57,500 of principal to common stock.

(3)  Converted $27,500 of principal to common stock.

(4)  Converted $121,132 of principal to common stock.

(5)  Converted $7,243 of principal to common stock.

(6)  Converted $58,500 of principal to common stock.

(7)  Converted $55,725 of principal to common stock.

 

Accrued interest on the above notes was $5,909 as September 30, 2017.

 

Debt discount expense including original issue discounts for the nine months ended September 30, 2017 and 2016, was $650,022 and $502,140, respectively.

 

Based on the fair value of the embedded conversion options on the day of issuance, a loss of $2,504,411 and $907,090 for the nine months ended September 30, 2017 and 2016, respectively, was recorded in the statement of operations.

 

NOTE 12—STOCK WARRANTS

 

The warrants issued by us are classified as equity. The fair value of the warrants calculated at the time of grant was recorded as an increase to additional paid-in-capital.

 

On December 24, 2015, we issued a warrant to purchase 150,000 shares of common stock to our chief executive officer. As of December 31, 2015, the warrant had vested for 87,500 shares, with an aggregate fair value of $612,500. As of December 31, 2016, the warrant vested for another 50,000 shares, with an aggregate fair value of $350,000. The remaining warrants for 12,500 shares vested in the three months ended March 31, 2017, with an aggregate fair value of $87,500. The aggregate fair value is based on the Black-Scholes-Merton pricing model using the following estimates: exercise price of $1.00, stock price of $7.00, 1.33% risk free rate, 842% volatility, and expected life of the warrant of three years.

 

On December 24, 2015, we issued a warrant to purchase 25,000 shares of common stock to one of our directors. The aggregate fair value of the warrant totaled $175,000 based on the Black-Scholes-Merton pricing model using the following estimates: exercise price of $1.00, stock price of $7.00, 1.33% risk free rate, 842% volatility, and expected life of the warrant of three years.


12


 

On December 24, 2015, we issued a warrant to purchase 12,500 shares of common stock to one of our directors. The aggregate fair value of the warrant totaled $87,500 based on the Black-Scholes-Merton pricing model using the following estimates: exercise price of $1.00, stock price of $7.00, 1.33% risk free rate, 842% volatility, and expected life of the warrant of three years.

 

On December 24, 2015, we issued a warrant to purchase 7,500 shares of common stock to a former director. As of December 31, 2015, the warrant had vested for 1,875 shares. The aggregate fair value of the vested warrant totaled $13,125 based on the Black-Scholes-Merton pricing model using the following estimates: exercise price of $1.00, stock price of $7.00, 1.33% risk free rate, 842% volatility, and expected life of the warrant of three years. On March 22, 2016, we accepted the resignation of Mr. Wollins resulting in the cancellation of the warrant for the remaining 5,625 shares.

 

On January 21, 2016, we issued a warrant to purchase 15,625 shares of common stock to an investor. The aggregate fair value of the warrant totaled $71,875 based on the Black-Scholes-Merton pricing model using the following estimates: exercise price of $8.00, stock price of $4.60, 2.02% risk free rate, 600% volatility, and expected life of the warrant of 10 years.

 

On January 24, 2016, pursuant to the terms of a consulting agreement, we issued a warrant to purchase 5,000 shares of common stock to an investor, with an exercise price of $4.60 per share, that expires January 23, 2017. The aggregate fair value of the warrant totaled $28,967 based on the Black-Scholes-Merton pricing model using the following estimates: exercise price of $4.60, stock price of $5.80, 0.47% risk free rate, 638% volatility, and expected life of the warrant of one year.

 

On April 28, 2016, pursuant to the terms of a promissory note with an investor, we issued a warrant to purchase 5,000 shares of common stock. The aggregate fair value of the warrant totaled $27,000 based on the Black-Scholes-Merton pricing model using the following estimates: exercise price of $1.00, stock price of $5.40, 0.91% risk free rate, 1,177% volatility, and expected life of the warrant of 2.68 years.

 

A summary of the outstanding warrants as of December 31, 2016 and September 30, 2017, is as follows:

 

 

Shares Available to

 

Weighted

 

Weighted

 

Purchase with

 

Average

 

Average

 

Warrants

 

Price

 

Fair Value

 

 

 

 

 

 

Outstanding, December 31, 2016

215,000

 

$1.60

 

$6.80

 

 

 

 

 

 

Issued

-

 

-

 

-

Exercised

-

 

-

 

-

Cancelled

-

 

-

 

-

Expired

5,000

 

-

 

-

Outstanding, September 30, 2017

210,000

 

$1.60

 

$6.80

 

 

 

 

 

 

Exercisable, September 30, 2017

210,000

 

$1.60

 

$6.80

 

 

 

Number

 

Weighted

 

 

Range of

 

Outstanding

 

Average Remaining

 

Weighted Average

Exercise Prices

 

09/30/2017

 

Contractual Life

 

Exercise Price

 

 

 

 

 

 

 

$1.00 - $8.00

 

210,000

 

1.7 years

 

$1.80


13


NOTE 13—STOCKHOLDERS’ EQUITY (DEFICIT)

 

Preferred Stock

 

On July 29, 2016, we filed an Amendment to the Articles of Incorporation Designating Rights, Privileges, and Preferences of Series A Preferred Stock with the Nevada Secretary of State respecting 1,515,000 shares of Series A Preferred Stock. On September 18, 2017, we filed a Certificate of Amendment to Certificate of Designation after Issuance of Class or Series for our Series A Preferred Stock to designate the rights, privileges, and preferences of 2,500,000 shares of the Series A Preferred Stock. Shares of Series A Preferred Stock may be converted at the holder’s election into shares of common stock, at the conversion rate of four shares of fully paid and nonassessable common stock for one share of Series A Preferred Stock. Each share is entitled to 100 votes, voting with the common stock as a single class.

 

On September 18, 2017, we filed a Certificate of Designation for our Series B Preferred Stock to designate the rights, privileges, and preferences of 2,000,000 shares of Series B Preferred Stock. Shares of Series B Preferred Stock may be converted at the holder’s election into shares of common stock, at the conversion rate of one share of fully paid and nonassessable common stock for one share of Series B Preferred Stock. Each share is entitled to 1,000 votes, voting with the common stock as a single class.

 

Both the Series A Preferred Stock and Series B Preferred Stock rank equal to our common stock respecting the payment of dividends and distribution of assets upon liquidation, dissolution, or winding up.

 

On September 20, 2017, we issued 500,000 shares of Series A Preferred Stock to each of our directors, for a total of 2,500,000 shares of Series A Preferred, in consideration of their future service on our board. The shares were valued using $0.0012, the closing stock price on the date of grant, based on the conversion rights of one preferred share for four common shares, for total noncash expense of $12,000.

 

On September 20, 2017, we issued 2,000,000 shares of Series B Preferred Stock to Beta Killers LLC, as consideration for and in exchange of its agreement to waive our prior defaults, release us from our obligations under the asset purchase agreement and related agreements, and enter into an additional statement of work. The shares were valued at $0.0012, the closing stock price on the date of grant, based on the conversion rights of one preferred share for one common shares, for total noncash expense of $2,400.

 

The issuance of both the Series A and Series B Preferred Stock constitutes an increase of control due to the conversion rights of both series. We fair valued the additional percentage of control obtained in excess of that already held by the parties who received the preferred stock. The value was determined using 1,688,420,598 shares of common stock and the closing price of $0.0012 on September 20, 2017, for a noncash expense of $1,155,793.

 

Common Stock

 

On February 2, 2017, we sold 36,000,000 shares of common stock to Kodiak Capital Group LLC for total cash proceeds of $148,680.

 

On June 15, 2017, we sold 21,000,000 shares of common stock to Kodiak Capital Group LLC for total cash proceeds of $22,000.

 

During the nine months ended September 30, 2017, we issued 1,225,000 shares of common stock for services to our chief executive officer. The shares were valued at the closing stock price on the date of grant, for a total noncash expense of $2,031.


14


 

The following table reflects the amounts of principal, interest, and fees converted, and the corresponding number of shares issued, in connection with outstanding convertible promissory notes during the nine months ended September 30, 2017:

 

Date

 

Note Holder

 

Shares Issued

 

Amount

 

 

 

 

 

 

 

01/03/2017

 

EMA Financial LLC

 

17,400,000

 

$   17,400.00

01/04/2017

 

EMA Financial LLC

 

19,200,000

 

19,200.00

01/05/2017

 

Adar Bays LLC

 

18,637,742

 

14,444.25

01/05/2017

 

Black Forest Capital LLC

 

10,000,000

 

7,750.00

01/06/2017

 

EMA Financial LLC

 

21,704,000

 

21,704.00

01/11/2017

 

Black Forest Capital LLC

 

15,000,000

 

11,625.00

01/13/2017

 

Black Forest Capital LLC

 

20,000,000

 

15,500.00

01/13/2017

 

EMA Financial LLC

 

24,556,110

 

24,556.11

01/13/2017

 

Microcap Equity Group LLC

 

22,851,306

 

17,138.48

01/17/2017

 

Black Forest Capital LLC

 

22,000,000

 

17,050.00

01/17/2017

 

Microcap Equity Group LLC

 

13,148,693

 

9861.52

01/17/2017

 

Tangiers Investment Group LLC

 

21,569,061

 

15,044.42

01/18/2017

 

Black Forest Capital LLC

 

22,500,000

 

17,437.50

01/18/2017

 

Kodiak Capital Group LLC

 

52,000,000

 

20,800.00

01/19/2017

 

Black Forest Capital LLC

 

11,939,846

 

9,253.38

01/19/2017

 

Kodiak Capital Group LLC

 

65,000,000

 

26,000.00

01/20/2017

 

Auctus Fund LLC

 

32,760,000

 

20,311.20

01/20/2017

 

Colonial Stock Transfer

 

13,289,051

 

8,970.11

01/24/2017

 

Kodiak Capital Group LLC

 

77,000,000

 

30,800.00

01/30/2017

 

Auctus Fund LLC

 

42,700,000

 

17,080.00

02/13/2017

 

Kodiak Capital Group LLC

 

24,716,275

 

9,886.51

02/13/2017

 

Kodiak Capital Group LLC

 

48,000,000

 

19,200.00

02/15/2017

 

Auctus Fund LLC

 

45,207,264

 

30,741.00

04/25/2017

 

Microcap Equity Group LLC

 

5,410,489

 

7,845.21

05/04/2017

 

Black Forest Capital LLC

 

10,344,828

 

15,000.00

05/10/2017

 

Black Forest Capital LLC

 

16,666,667

 

12,500.00

06/14/2017

 

Black Forest Capital LLC

 

20,833,334

 

12,500.00

06/20/2017

 

Black Forest Capital LLC

 

25,000,000

 

15,000.00

06/12/2017

 

Microcap Equity Group LLC

 

20,992,286

 

12,595.72

06/19/2017

 

Adar Bays LLC

 

8,333,333

 

5,000.00

06/21/2017

 

Adar Bays LLC

 

58,000,000

 

34,800.00

07/11/2017

 

Adar Bays LLC

 

30,965,477

 

20,127.56

07/17/2017

 

Adar Bays LLC

 

63,076,923

 

41,000.00

07/24/2017

 

Black Forest Capital LLC

 

44,690,831

 

29,049.04

08/03/2017

 

Adar Bays LLC

 

26,606,154

 

17,294.00

08/18/2017

 

Black Forest Capital LLC

 

42,857,143

 

30,000.00

08/21/2017

 

Adar Bays LLC

 

22,142,857

 

15,500.00

08/28/2017

 

Adar Bays LLC

 

27,272,727

 

15,000.00

08/28/2017

 

Black Forest Capital LLC

 

52,500,000

 

28,875.00

09/11/2017

 

Adar Bays LLC

 

25,454,545

 

14,000.00

09/11/2017

 

Black Forest Capital LLC

 

36,363,637

 

20,000.00

09/14/2017

 

Adar Bays LLC

 

26,503,740

 

13,251.87

09/19/2017

 

Black Forest Capital LLC

 

50,000,000

 

25,000.00

09/29/2017

 

Black Forest Capital LLC

 

70,000,000

 

24,500.00

 

 

 

 

1,345,194,319

 

 


15


NOTE 14—SUBSEQUENT EVENTS

 

In accordance with ASC 855-10, Subsequent Events ¸ we have analyzed our operations subsequent to September 30, 2017, through the date the financial statements were available to be issued, and have determined that we do not have any material subsequent events to disclose in these financial statements.

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion should be read in conjunction with our condensed consolidated financial statements and notes to our financial statements included elsewhere in this report. This discussion contains forward-looking statements that involve risks and uncertainties. Actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors discussed elsewhere in this report.

 

This report contains statements that may be considered forward-looking statements, such as statements relating to our anticipated revenues, gross margin and operating results, future performance and operations, plans for future expansion, capital spending, sources of liquidity, and financing sources. This forward-looking information involves important risks and uncertainties that could significantly affect anticipated results in the future, and accordingly, such results may differ from those expressed in any forward-looking statements made herein. These risks and uncertainties include those relating to our liquidity requirements, the continued growth of the software industry, the success of our product development, marketing and sales activities, vigorous competition in the software industry, dependence on existing management, leverage and debt service (including sensitivity to fluctuations in interest rates), domestic or global economic conditions, the inherent uncertainty and costs of prolonged arbitration or litigation, and changes in federal or state tax laws or the administration of such laws.

 

Introduction

 

We create, develop, and commercialize innovative solutions for the expanding medical and recreational cannabis community. Our solutions enhance customer service and provider efficiency, including customer loyalty software applications; create producer and retailer opportunities through the distribution of our own brands; and assist with marketing and branding for product companies. We do not grow, distribute, or sell cannabis or products containing cannabis.

 

We began our cannabis industry activity with the organization of a predecessor privately held entity in late 2013 to create, develop, and commercialize innovative solutions to solve customer service and provider problems, create producer and retailer opportunities, build retail customer loyalty, and streamline the connections among the producer, seller, and consumer/patient segments for the growing medical and recreational cannabis community. Since organization, we have focused on raising capital, creating new products, building marketing and distribution capability and channels, and pursuing complementary strategic alliances and acquisitions.

 

In August 2014, CannaSys, Inc., then called Thermal Tennis, Inc., acquired our predecessor engaged in cannabis industry-related activities as noted above in a transaction recognized as a reverse acquisition of the company by the predecessor private company. This discussion relates to the financial statements of the privately held predecessor entity for all periods before the reverse acquisition.

 

Results of Operations for the Three Months Ended September 30, 2017,

Compared to the Three Months Ended September 30, 2016

 

Revenue and Costs of Goods Sold

 

Revenue was $0 and $499 for the three months ended September 30, 2017 and 2016, respectively, representing a decrease of $499, or 100%, in the current period. Our cost of goods sold was $0 and $0 for the three months ended September 30, 2017 and 2016, respectively.


16


Operating Expenses

 

Stock-based compensation expense was $13,406 and $119,125 for the three months ended September 30, 2017 and 2016, respectively, representing a decrease of $105,719 in the current period. The decrease is due to the lower stock price for preferred stock issued to a service provider and our directors (Note 13).

 

Professional fees were $121,246 and $95,286 for the three months ended September 30, 2017 and 2016, respectively, representing an increase of $25,960, or 27.2%, in the current period. The increase can be largely attributed to audit and legal fees.

 

Salary and wage expense was $57,175 and $49,092 for the three months ended September 30, 2017 and 2016, respectively, representing an increase of $8,083, or 16.4%, in the current period. The increase is attributed to severance and bonus paid to the former chief executive officer.

 

General and administrative expense was $109,915 and $68,240 for the three months ended September 30, 2017 and 2016, respectively, representing an increase of $41,675, or 61%, in the current period. The increase in the current period can be attributed to increases in amortization, advertising/promotional, and consulting expenses.

 

Other Income and Expense

 

For the three months ended September 30, 2017, we had total other expense of $1,784,530, compared to $1,335,360 for the three months ended September 30, 2016. For the three months ended September 30, 2017, we recorded interest expense of $4,822, amortization of debt discount and loan financing fees of $189,068, penalties and settlements costs for conversions of $85,741, and a loss on the issuance of convertible debt of $349,106. In the prior period, we recorded interest expense of $12,749, amortization of debt discount of $86,291, a loss on the issuance of convertible debt of $418,079, a loss on the write down of assets of $258,766, impairment loss on investment of $599,475, a loss due the increased valuation of preferred stock of $1,155,793 (Note 13), and a $40,000 gain on the forgiveness of debt.

 

Net Loss

 

For the three months ended September 30, 2017, we had a net loss of $2,086,272, as compared to a net loss of $1,666,604 in the prior period, an increase of $419,668. This increase in the current period can be attributed to the increase expense recognized due to the voting rights of the preferred stock that was issued.

 

Results of Operations for the Nine Months Ended September 30, 2017,

Compared to the Nine Months Ended September 30, 2016

 

Revenue and Costs of Goods Sold

 

Revenue was $0 and $59,150 for the nine months ended September 30, 2017 and 2016, respectively, representing a decrease of $59,150, or 100%, in the current period. On March 29, 2017, we announced that we signed a non-binding letter of intent to acquire Alliance Financial Network, Inc., a financial technology company providing transaction solutions to the cannabis and other industries. During the first quarter of 2017, our primary business efforts were focused on structuring and due diligence related to that transaction. Those negotiations continued until May 9, 2017, when we announced that the transaction had been terminated as a result of our inability to come to suitable transaction terms with Alliance Finance Network, Inc. among other reasons. The decreases in revenue and associated cost of goods sold during the second quarter 2017 are due to our focus on the aforementioned transaction.  

 

Our cost of goods sold was $0 and $24,260 for the nine months ended September 30, 2017 and 2016, respectively, a decrease of $24,260, or 100%.

 

Operating Expenses

 

Stock-based compensation expense was $101,531 and $604,592 for the nine months ended September 30, 2017 and 2016, respectively, representing a decrease of $503,061, in the current period. Compensation expense in the current consists of $12,000 in noncash expense for the issuance of preferred stock for services (Note 13) and $87,500 for


17


warrants previously issued. Compensation expense in the prior year is largely due to warrants issued to officers, consultants, and other service providers.

 

Professional fees were $251,156 and $307,713 for the nine months ended September 30, 2017 and 2016, respectively, representing a decrease of $56,557, or 18.3%, in the current period. The decrease can be largely attributed to a decrease in legal fees.

 

Salary and wage expense was $141,175 and $183,793 for the nine months ended September 30, 2017 and 2016, respectively, representing a decrease of $42,618, or 23.1%, in the current period. The decrease in the current period is due to a decrease in officer compensation.

 

General and administrative expense was $238,052 and $198,261 for the nine months ended September 30, 2017 and 2016, respectively, representing an increase of $39,791, or 20%, in the current period.

 

Other Income and Expense

 

For the nine months ended September 30, 2017, we had total other expense of $3,253,191, compared to $2,256,675 for the nine months ended September 30, 2016. For the nine months ended September 30, 2017, we recorded interest expense of $15,017, amortization of debt discount and loan financing fees of $650,02, penalties and settlements costs for conversions of $85,741, and a loss on the issuance of convertible debt of $2,504,411. In the prior period, we recorded interest expense of $29,204, amortization of debt discount of $502,140, a loss on the issuance of convertible debt of $907,090, a loss on the write down of assets of $258,766, impairment loss on investment of $599,475, a loss due the increased valuation of preferred stock of $1,155,793 (Note 13), and a $40,000 gain on the forgiveness of debt.

 

Net Loss

 

For the nine months ended September 30, 2017, we had a net loss of $3,962,930, as compared to a net loss of $3,516,144 in the prior period, an increase of $446,786. This increase is the direct result of the large loss on convertible debt resulting from the beneficial conversion features of that debt.

 

Liquidity and Capital Resources

 

During the nine months ended September 30, 2017 and 2016, we used cash of $609,624 and $307,860, respectively, in operating activities. During the nine months ended September 30, 2017 and 2016, we used $25,000 and $0, respectively, in investing activities. During the nine months ended September 30, 2017 and 2016, we received $629,557 and $302,000, respectively, from financing activities.

 

Our current business expenses average approximately $30,000 per month, excluding capital expenditures specific to new product launches. We continue to focus on reducing our monthly business expenses through cost reductions and operational streamlining. Currently, we do not have enough cash on hand to sustain our business operations and, alongside expected revenue, we expect to access external capital resources in the near future. At the moment, we are seeing increased adoption across our business lines, but we cannot guarantee this will continue.

 

We anticipate also accessing the capital markets in order to fund future research and development, as well as expand product offerings to include future versions of products and possible acquisitions of ancillary products and services. To the extent that funding is available, we have budgeted $650,000 for capital expenditures and other costs during the next 12 months, consisting of $200,000 for enhanced software development, $350,000 for debt retirement (and, if necessary, to provide for refinancing or extensions of our existing debt, including principal and any interest due under the terms of our current financing agreements with our capital partners), and $100,000 for legal, audit and accounting expenses. We may seek additional debt financing, although we cannot guarantee what structures our sources of financing may choose in the future, and there is no guarantee we will be able to secure additional funding. In addition, the vast majority of our debt may be converted into common stock, in which case we would not have to retire it; the investors are able to convert the debt into our shares. If we were to retire all of our outstanding debt, including the convertible promissory notes, and pay the maximum potential interest due, we would need to budget approximately $350,000.


18


It is possible that additional external cash will be required during the next 12 months, particularly if we seek to develop new products, need to fund new strategic relationships, or enter new markets not now anticipated or if projected revenues are not realized.

 

Our efforts are focused on increasing revenue while we explore external funding alternatives as our current cash is insufficient to fund operations for the next 12 months. Although our independent auditors have expressed substantial doubt about our ability to continue as a going concern, we feel that our revenue potential is sufficient for our business to continue as a going concern. However, in order to expand our product offerings, we expect that we will require additional investments and revenue.

 

As we continue to develop new products and identify specific commercialization opportunities, we will focus on those product markets and opportunities for which we might be able to get external funding through joint venture agreements, strategic partnerships, or other direct investments.

 

Going Concern

 

These interim unaudited financial statements have been prepared on the going concern basis, which assumes that adequate sources of financing will be obtained as required and that our assets will be realized and liabilities settled in the ordinary course of business. Accordingly, the interim unaudited financial statements do not include any adjustments related to the recoverability of assets and classification of assets and liabilities that might be necessary should we not be unable to continue as a going concern.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Critical Accounting Policies

 

We have identified the policies outlined below as critical to our business operations and an understanding of our results of operations. The list is not intended to be a comprehensive list of all of our accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated U.S. GAAP, with no need for management’s judgment in their application. The impact and any associated risks related to these policies on our business operations is discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations when such policies affect our reported and expected financial results. For a detailed discussion on the application of these and other accounting policies, see the notes to our December 31, 2016, financial statements. Note that our preparation of the financial statements requires us to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities at the date of our financial statements, and the reported amounts of revenue and expenses during the reporting period. We cannot assure that actual results will not differ from those estimates.

 

Stock-based Compensation

 

We account for equity-based transactions with nonemployees under the provisions of Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 505-50, Equity-Based Payments to Non-Employees (“ASC 505-50”). ASC 505-50 establishes that equity-based payment transactions with non-employees shall be measured at the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable. The fair value of common stock issued for payments to nonemployees is measured at the market price on the date of grant. The fair value of equity instruments, other than common stock, is estimated using the Black-Scholes option valuation model. In general, we recognize the fair value of the equity instruments issued as deferred stock compensation and amortize the cost over the term of the contract.


19


We account for employee stock-based compensation in accordance with the guidance of ASC 718, Compensation—Stock Compensation , which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair values. The fair value of the equity instrument is charged directly to compensation expense and credited to additional paid-in capital over the period during which services are rendered.

 

Revenue Recognition and Cost of Goods Sold

 

We follow ASC 605-10-S99-1, Revenue Recognition , for revenue recognition. We will recognize revenue when it is realized or realizable and earned. We consider revenue realized or realizable and earned when all of the following criteria are met: (i) persuasive evidence of an arrangement exists; (ii) the product has been shipped or the services have been rendered to the customer; (iii) the sales price is fixed or determinable; and (iv) collectability is reasonably assured.

 

We generated revenue from: (1) customized software development (software developed for customers on a custom-made basis); and (2) software licensing (licensing existing portfolio of software products to customers either for a one-time fee or on a recurring monthly-fee basis).

 

We allocated cost of goods sold for both forms of revenue on a pro-rata basis through either direct outsourcing of development resources or direct costs associated with our employees or contractors.  

 

Income Taxes

 

We follow ASC 740-10-30, Income Taxes-Initial Measurement, which requires recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred tax assets and liabilities are based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the fiscal year in which the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the fiscal years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of income in the period that includes the enactment date.

 

We adopted ASC 740-10-25, Income Taxes—Recognition . ASC 740-10-25 addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC 740-10-25, we may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. ASC 740-10-25 also provides guidance on derecognition, classification, interest and penalties on income taxes, and accounting in interim periods and requires increased disclosures. We had no material adjustments to our liabilities for unrecognized income tax benefits according to the provisions of ASC 740-10-25.

 

Recently Issued Accounting Pronouncements

 

In February 2016, the FASB issued ASU 2016-02— Leases (Topic 842) . The guidance in ASU 2016-02 supersedes the lease recognition requirements in ASC 840, Leases (FAS 13). ASU 2016-02 requires an entity to recognize assets and liabilities arising from a lease for both financing and operating leases, along with additional qualitative and quantitative disclosures. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, with early adoption permitted. We are currently evaluating the effect this standard will have on our financial statements.


20


In June 2016, the FASB issued ASU 2016-15— Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (a consensus of the FASB’s Emerging Issues Task Force) . The new guidance is intended to reduce diversity in practice in how certain transactions are classified in the statement of cash flows. The ASU is effective for public companies for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Early adoption is permitted, including interim periods within those fiscal years. An entity that elects early adoption must adopt all of the amendments in the same period. The guidance requires application using a retrospective transition method. We are currently evaluating the effects, if any, that the adoption of this guidance will have on our cash flows.

 

We have implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and we do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial position or results of operations.

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

As a smaller reporting company, we are not required to provide the information required by this item.

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

As of September 30, 2017, we carried out an evaluation, under the supervision and with the participation of management, including our chief executive and financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based upon that evaluation, management concluded that our disclosure controls and procedures were not effective as of September 30, 2017, to provide reasonable assurance that the information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the periods prescribed by U.S. Securities and Exchange Commission and that such information is accumulated and communicated to management, including our chief executive and financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

In designing and evaluating disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable, not absolute assurance of achieving the desired objectives. Also, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. The design of any system of controls is based, in part, upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control over Financial Reporting

 

There has been no change in our internal control over financial reporting during the nine months ended September 30, 2017, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


21


PART II—OTHER INFORMATION

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

During the quarter ended September 30, 2017, we issued:

 

· 30,965,477 shares of our common stock upon conversion of principal, interest, or fees of $20,128, at $0.00065, per share, pursuant to a promissory note to an unaffiliated noteholder; 

 

· 63,076,923 shares of our common stock upon conversion of principal, interest, or fees of $41,000, at $0.00065, per share, pursuant to a promissory note to an unaffiliated noteholder; 

 

· 44,690,831 shares of our common stock upon conversion of principal, interest, or fees of $29,049, at $0.00065, per share, pursuant to a promissory note to an unaffiliated noteholder; 

 

· 26,606,154 shares of our common stock upon conversion of principal, interest, or fees of $17,294, at $0.00065, per share, pursuant to a promissory note to an unaffiliated noteholder; 

 

· 42,857,143 shares of our common stock upon conversion of principal, interest, or fees of $30,000, at $0.0007, per share, pursuant to a promissory note to an unaffiliated noteholder; 

 

· 22,142,857 shares of our common stock upon conversion of principal, interest, or fees of $15,500, at $0.0007, per share, pursuant to a promissory note to an unaffiliated noteholder; 

 

· 27,272,727 shares of our common stock upon conversion of principal, interest, or fees of $15,000, at $0.00055, per share, pursuant to a promissory note to an unaffiliated noteholder;  

 

· 52,500,000 shares of our common stock upon conversion of principal, interest, or fees of $28,875, at $0.00055, per share, pursuant to a promissory note to an unaffiliated noteholder; 

 

· 25,454,545 shares of our common stock upon conversion of principal, interest, or fees of $14,000, at $0.00055, per share, pursuant to a promissory note to an unaffiliated noteholder; 

 

· 36,363,637 shares of our common stock upon conversion of principal, interest, or fees of $20,000, at $0.0005, per share, pursuant to a promissory note to an unaffiliated noteholder; 

 

· 26,503,740 shares of our common stock upon conversion of principal, interest, or fees of $13,252, at $0.0005, per share, pursuant to a promissory note to an unaffiliated noteholder; 

 

· 50,000,000 shares of our common stock upon conversion of principal, interest, or fees of $25,00, at $0.0005, per share, pursuant to a promissory note to an unaffiliated noteholder; and 

 

· 70,000,000 shares of our common stock upon conversion of principal, interest, or fees of $24,500, at $0.00035, per share, pursuant to a promissory note to an unaffiliated noteholder. 

 

The issuances of the shares to the above parties were made in reliance on the exemption from registration provided in Section 4(a)(2) of the Securities Act of 1933, as amended, for transactions not involving any public offering. The parties confirmed the foregoing and acknowledged, in writing, that (i) the securities must be acquired and held for the buyer’s own account and not with a present view towards the public sale or distribution thereof, except pursuant to sales registered or exempted from registration under the Securities Act; and (ii) the buyers are accredited investors under the meaning of Rule 506 of Regulation D under the Securities Act. All certificates evidencing the shares issued bear or will bear a restrictive legend until such time as the shares have been registered under the Securities Act or may be sold pursuant to Rule 144 under the Securities Act without any restriction. No underwriter participated in the offer and sale of these securities, and no commission or other remuneration was paid or given directly or indirectly in connection therewith.


22


ITEM 6. EXHIBITS

 

The following exhibits are filed as a part of this report:

 

Exhibit

Number*

 

 

Title of Document

 

 

Location

 

 

 

 

 

Item 3

 

Articles of Incorporation and Bylaws

 

 

3.06

 

Amendment to Certificate of Designation after Issuance of Class of Series

 

Incorporated by reference from current report on Form 8-K filed September 19, 2017

 

 

 

 

 

3.07

 

Certificate of Designation

 

Incorporated by reference from current report on Form 8-K filed September 19, 2017

 

 

 

 

 

 

 

 

 

 

Item 10

 

Material Contracts

 

 

10.74

 

Executive Employment Agreement, together Grant of Restricted Stock and Confidentiality and Proprietary Rights Agreement, between CannaSys, Inc. and Patrick G. Burke, effective July 1, 2017

 

Incorporated by reference from current report on Form 8-K filed July 11, 2017

 

 

 

 

 

10.75

 

Promissory Note to Michael A. Tew dated June 30, 2017

 

Incorporated by reference from current report on Form 8-K filed July 11, 2017

 

 

 

 

 

10.76

 

Separation and Mutual Release Agreement between CannaSys, Inc. and Michael A. Tew effective June 30, 2017

 

Incorporated by reference from current report on Form 8-K filed July 11, 2017

 

 

 

 

 

10.77

 

Consulting Agreement between CannaSys, Inc. and Michael A. Tew effective July 1, 2017

 

Incorporated by reference from current report on Form 8-K filed July 11, 2017

 

 

 

 

 

10.78

 

Securities Purchase Agreement between CannaSys, Inc., and BNA Investment Capital, LLC

 

Incorporated by reference from current report on Form 8-K filed September 7, 2017

 

 

 

 

 

10.79

 

Convertible Promissory Note up to $275,000 issued to BNA Investment Capital, LLC

 

Incorporated by reference from current report on Form 8-K filed September 7, 2017

 

 

 

 

 

Item 31

 

Rule 13a-14(a)/15d-14(a) Certifications

 

 

31.01

 

Certification of Principal Executive  and Principal Financial Officer Pursuant to Rule 13a-14

 

This filing.

 

 

 

 

 

Item 32

 

Section 1350 Certifications

 

 

32.01

 

Certification of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

This filing.


23


Exhibit

Number*

 

 

Title of Document

 

 

Location

Item 101**

 

Interactive Data File

 

 

101.INS

 

XBRL Instance Document

 

This filing.

 

 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema

 

This filing.

 

 

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase

 

This filing.

 

 

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase

 

This filing.

 

 

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase

 

This filing.

 

 

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase

 

This filing.

_______________

* All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document. Omitted numbers in the sequence refer to documents previously filed as an exhibit.  

** Users of this data are advised that, pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or Annual Report for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Exchange Act of 1934 and otherwise are not subject to liability.  

 

 

SIGNATURE PAGE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

CANNASYS, INC.

 

 

 

 

 

 

 

 

Dated: November 20, 2017

By:

/s/ Patrick G. Burke

 

 

Patrick G. Burke, Chief Executive Officer,

 

 

Chief Financial Officer, and Secretary


24